Fred van Leeuwen

20PUBLICATIONS
60CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Tumour immunologyGenome structure and regulationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 29, 2026
DOT1L Shapes ncPRC1-Target Gene Repression to Maintain Germinal Center B Cell Identity of Diffuse Large B cell Lymphoma.

|Mar 18, 2026
Histone methyltransferase DOT1L differentially affects the development of dendritic cell subsets.

Rianne G Bouma, Willem-Jan de Leeuw, Aru Z Wang

|Dec 12, 2025
Histone methyltransferase DOT1L maintains cell state and restricts cytotoxic potential of CD8 T cells.

Muddassir Malik, Willem-Jan de Leeuw, Muhammad Assad Aslam

|Aug 05, 2025
Should I stay or should I go: TFIIIC as assembly factor and barrier in RNA polymerase III transcription.

Wolfram Seifert-Davila, Maria Elize van Breugel, Fred van Leeuwen

|Jan 10, 2025
Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of diffuse large B-cell lymphoma.

Camiel Göbel, Rachele Niccolai, Marnix H P de Groot

|Apr 26, 2024
The choreography of chromatin in RNA polymerase III regulation.

Maria Elize van Breugel, Alan Gerber, Fred van Leeuwen

Pageof 4

Frequent Collaborators

6 joint publications

Heinz Jacobs

4 joint publications

Eliza Mari Kwesi-Maliepaard

4 joint publications

Muhammad Assad Aslam

3 joint publications

Hanneke Vlaming